Friday 22 February 2019

Fifteen women given all-clear died before being told of misdiagnosis

HSE chief Tony O'Brien said it was known that smear testing has a failure rate.
HSE chief Tony O'Brien said it was known that smear testing has a failure rate.

Fifteen women who developed cervical cancer died without knowing they had been the victim of a misdiagnosis.

The news that they had been wrongly given the all-clear after having a smear test with CervicalCheck will only be broken to their loved ones this week.

The deceased patients were among 208 women whose smear test readings missed abnormalities over the past 10 years, leaving them to develop cervical cancer.

Only 46 of these women were told that an internal review of their case was carried out by CervicalCheck, unlocking the mystery behind their cancer misdiagnosis.

HSE director Patrick Lynch, who led a team that investigated CervicalCheck files in recent days, revealed 17 of the women have died but only two were told of the review of their case before they passed away.


"The next of kin will be informed," he said.

It is unclear if all the women died of cervical cancer.

"It is a fundamental commitment in healthcare that if somebody is the subject of a review they must be informed of this and the outcome," Mr Lynch added.

The all-male team was revealing its findings following heightened public anxiety about standards at CervicalCheck.

The concern emerged after Limerick mother-of-two Vicky Phelan, who has terminal cervical cancer, was not informed of an internal review of her failed smear test for three years.

The 208 women were treated in 13 hospitals, including in Castlebar, Cork, the Coombe, Dundalk, the National Maternity Hospital Holles St, Limerick, the Rotunda, Sligo, Tallaght, Dundalk, Wexford and Letterkenny.

"They will be contacted dir- ectly by the hospital. Most of these contacts will happen today and tomorrow," Mr Lynch said.

"They will be offered an appointment by a senior clinician. We need to be open with all those who use our services."

He said he was confident the doctors will treat the women or their relatives sensitively.

It emerged last week that CervicalCheck had a policy of leaving it to the judgment of doctors on whether to tell patients of their reviews, and in the case of deceased women it could be just noted in their medical file.

HSE chief Tony O'Brien said it was known that smear testing has a failure rate.

He defended the use of laboratory facilities in the US to read half of CervicalCheck smears, saying their standards were quality-assured.

They are tailored to reading smears which are taken every three to five years from Irish women.

"If there is a concern about an original result it goes back to the original lab," he said.

"It goes to a second lab. There are layers of safeguards built in."

The internal reviews which were carried out by CervicalCheck looked at the original interpretation of the smear test result and rechecked it.


In the case of 208 women, the second team which examined the result found the original negative reading was wrong.

Women should either have been referred for a diagnostic procedure or sent for a second smear test.

By the time they found out they had cancer their treatment was delayed.

Women who are anxious about their smear test reading in the wake of last week's controversy are to be offered another free of charge.

The team would not comment on why the reports were kept secret from the women.

CervicalCheck is to undergo an inquiry by Health Information and Quality Authority (Hiqa), as well as an external review.

Obstetrician Dr Peter Mc- Kenna, who is now heading the HSE's women's health programme, said that from now on a new system will be in place.

If a woman develops cancer after a mistaken test reading she will be informed of the review and be part of it, he added.

CervicalCheck is to bring in HPV-related cervical screening next autumn.

This is aimed at increasing the rate of accuracy and reduce the number of tests women must undergo in a lifetime, the HSE confirmed.

It will also be reviewed by international experts, who will look at areas such as the quality of testing and whether the failure rate is on a par with norms for a screening service.

Promoted articles

Entertainment News